References in this quarterly report on Form
10-Q
(the "Quarterly Report") to "we," "us" or the "Company" refer to Golden Falcon
Acquisition Corp. References to our "management" or our "management team" refer
to our officers and directors, and references to the "Sponsor" refer to Golden
Falcon Sponsor Group, LLC. The following discussion and analysis of the
Company's financial condition and results of operations should be read in
conjunction with the condensed financial statements and the notes thereto
contained elsewhere in this Quarterly Report. Certain information contained in
the discussion and analysis set forth below includes forward-looking statements
that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements



This Quarterly Report includes "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended (the "Securities Act")
and Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") that are not historical facts and involve risks and
uncertainties that could cause actual results to differ materially from those
expected and projected. All statements, other than statements of historical fact
included in this Quarterly Report including, without limitation, statements in
this "Management's Discussion and Analysis of Financial Condition and Results of
Operations" regarding the Company's financial position, business strategy and
the plans and objectives of management for future operations, are
forward-looking statements. Words such as "expect," "believe," "anticipate,"
"intend," "estimate," "seek" and variations and similar words and expressions
are intended to identify such forward-looking statements. Such forward-looking
statements relate to future events or future performance, but reflect
management's current beliefs, based on information currently available. A number
of factors could cause actual events, performance or results to differ
materially from the events, performance and results discussed in the
forward-looking statements. For information identifying important factors that
could cause actual results to differ materially from those anticipated in the
forward-looking statements, please refer to the Risk Factors section of our
Annual Report on Form
10-K
for the fiscal year ended December 31, 2021 (the "Form
10-K")
filed with the U.S. Securities and Exchange Commission (the "SEC") on March 31,
2022, as well as Item 1A, Part II of this Quarterly Report. The Company's
securities filings can be accessed on the EDGAR section of the SEC's website at
www.sec.gov. Except as expressly required by applicable securities law, the
Company disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information, future events
or otherwise.

Overview

We are a blank check company formed under the laws of the State of Delaware on August 24, 2020, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our business combination using cash from the proceeds of the initial public offering and the sale of the private placement warrants, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.

Results of Operations



We have neither engaged in any operations nor generated any revenues to date.
Our only activities through March 31, 2022 were organizational activities, those
necessary to prepare for the Initial Public Offering, described below, and,
after our Initial Public Offering, identifying a target company for a business
combination. We do not expect to generate any operating revenues until after the
completion of our business combination. We generate
non-operating
income in the form of interest income on marketable securities held in the trust
account, along with
non-operating
income or expense related to the change in fair value of the warrant liabilities
and the Convertible Note. We incur expenses as a result of being a public
company (for legal, financial reporting, accounting and auditing compliance), as
well as for due diligence expenses.

For the three months ended March 31, 2022, we had a net income of $9,383,232, which consists of interest earned on marketable securities held in the trust account of $174,761, unrealized gain on marketable securities held in the trust account of $65,646, change in fair value of convertible promissory note - related party of $132,122 and change in fair value of warrant liabilities of $9,398,310, partially offset by formation and operational costs of $387,608.

For the three months ended March 31, 2021, we had a net income of $17,929,444, which consists of interest earned on marketable securities held in the trust account of $63,112 and change in fair value of warrant liabilities of $18,828,000, partially offset by formation and operational costs of $959,946 and unrealized loss on marketable securities held in the trust account of $1,722.

Liquidity and Capital Resources

On December 22, 2020, we consummated the initial public offering of 34,500,000 units, at $10.00 per unit, which included the full exercise by the underwriters of their over-allotment option in the amount of 4,500,000 units, generating gross proceeds of $345,000,000. Simultaneously with the closing of the initial public offering, we consummated the sale of 8,900,000 private placement warrants to the Sponsor at a price of $1.00 per warrant, generating gross proceeds of $8,900,000.


                                       19

--------------------------------------------------------------------------------

Table of Contents

Following the initial public offering, the full exercise of the over-allotment option, and the sale of the private placement warrants, a total of $345,000,000 was placed in the trust account. We incurred $19,606,206 in transaction costs, including $6,900,000 of underwriting fees, net of reimbursement, $12,075,000 of deferred underwriting fees and $631,206 of other offering costs.

For the three months ended March 31, 2022, net cash used in operating activities was $96,508. Net income of $9,383,232 was affected by the change in fair value of warrant liabilities of $9,398,310, change in fair value of convertible promissory note - related party of $132,122, interest earned on marketable securities held in trust account of $174,761 and an unrealized gain on marketable securities held in trust account of $65,646. Changes in operating assets and liabilities provided $291,099 of cash from operating activities.

For the three months ended March 31, 2021, net cash used in operating activities was $66,531. Net income of $17,929,444 was affected by the change in fair value of warrant liabilities of $18,828,000, interest earned on marketable securities held in trust account of $63,112 and an unrealized loss on marketable securities held in trust account of $1,722. Changes in operating assets and liabilities provided $893,415 of cash from operating activities.

For the three months ended March 31, 2022, net cash provided by financing activities was $300,000 as a result of the drawdowns on the Convertible Note.

At March 31, 2022 we had cash and marketable securities held in the trust account of $345,411,246 consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the trust account may be used by us to pay taxes. Through March 31, 2022, we have not withdrawn any interest earned from the trust account.

We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less deferred underwriting commissions and income taxes payable), to complete our business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

At March 31, 2022, we had cash of $215,372 outside of the trust account and accounts payable and accrued expenses of $351,266. We intend to use the funds held outside the trust account in addition to the remaining amount unborrowed on the Convertible Promissory note of $379,889 primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor or certain of our directors and officers may, but are not obligated to, lend us funds as may be required. If we complete a business combination, we would repay such lent amounts. In the event that a business combination does not close, we may use a portion of the working capital held outside the trust account to repay such lent amounts but no proceeds from our trust account would be used for such repayment. On September 13, 2021, the Sponsor agreed to lend us an aggregate of up to $1,000,000 pursuant to the Convertible Note (as defined below) for working capital purposes. At March 31, 2022, there was $620,111 of cumulative cash advanced under the convertible promissory note. The convertible promissory note was valued using the fair value method. The change in the fair value of the note recorded in the statement of operations for the three months ended March 31, 2022 was $132,122 resulting in a fair value of the convertible note of $288,100 (see Note 9).

Going Concern

As of March 31, 2022, the Company had $215,372 in its operating bank accounts, $345,411,246 in marketable securities held in the Trust Account to be used for a Business Combination, or to repurchase or redeem its stock in connection therewith and working capital of $53,940, which excludes the permitted withdrawal should the Company elect to withdraw from the Trust Account for franchise taxes payable of $250,050. As of March 31, 2022, $411,246 of the amount on deposit in the Trust Account represented interest income, $64,646 of which was recorded as an unrealized gain. Interest income earned on the Trust Account is available to pay the Company's tax obligations. As of March 31, 2022, no amounts were withdrawn from the Trust account to pay the Company's tax obligations.

The Company may raise additional capital through loans or additional investments from the Sponsor or an affiliate of the Sponsor or certain of its directors and officers. The Sponsor may but is not obligated to (except as described below), lend the Company funds, from time to time in whatever amounts it deems reasonable in its sole discretion, to meet the Company's working capital needs. On September 13, 2021, the Sponsor agreed to lend the Company an aggregate of up to $1,000,000 for working capital purposes pursuant to a convertible promissory note. The Company had drawn an aggregate of $620,111 under the convertible promissory note as of March 31, 2022, which includes drawdowns of $150,000 on January 31, 2022 and $150,000 on March 31, 2022. There can be no assurance that the Company will be able to obtain additional financing, however. Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because the Company becomes obligated to redeem a significant number of its public shares upon consummation of its Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, the Company would only complete such financing simultaneously with the completion of its Business Combination.

If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.



In connection with the Company's assessment of going concern considerations in
accordance with ASC Subtopic
205-40,
Presentation of Financial Statements - Going Concern, pursuant to its Amended
and Restated Certificate of Incorporation, the Company has until December 22,
2022 to consummate a Business Combination. If a Business Combination is not
consummated by this date, or its stockholders have not approved an extension,
there will be a mandatory liquidation and subsequent dissolution of the Company.
Although the Company intends to consummate a Business Combination on or before
December 22, 2022, and may seek an extension, it is uncertain that the Company
will be able to consummate a Business Combination, or obtain an extension, by
this time. This, as well as its liquidity condition, raise substantial doubt
about the Company's ability to continue as a going concern. No adjustments have
been made to the carrying amounts of assets or liabilities should the Company be
required to liquidate after December 22, 2022.

                                       20

--------------------------------------------------------------------------------


  Table of Contents

Off-Balance
Sheet Arrangements

We did not have any
off-balance
sheet arrangements as of March 31, 2022.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a monthly fee of $10,000 for certain administrative, research, transaction and other support services. We began incurring these fees on December 22, 2020 and will continue to incur these fees monthly until the earlier of the completion of the business combination and our liquidation.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $12,075,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the trust account solely in the event that we complete a business combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. Our critical accounting policies are presented below:

Warrant Liabilities and Convertible Note - Related Party



We account for warrants as either equity-classified or liability-classified
instruments based on an assessment of the warrant's specific terms and
applicable authoritative guidance in Financial Accounting Standards Board
("FASB") Accounting Standards Codification ("ASC") 480, Distinguishing
Liabilities from Equity ("ASC 480") and ASC 815, Derivatives and Hedging ("ASC
815"). The assessment considers whether the warrants are freestanding financial
instruments pursuant to ASC 480, meet the definition of a liability pursuant to
ASC 480, and whether the warrants meet all of the requirements for equity
classification under ASC 815, including whether the warrants are indexed to our
own Class A common stock, among other conditions for equity classification. This
assessment, which requires the use of professional judgment, is conducted at the
time of warrant issuance and as of each subsequent quarterly period end date
while the warrants are outstanding. The Company accounts for its Convertible
Note under ASC 815, Derivatives and Hedging ("ASC 815"). Under
815-15-25,
the election can be at the inception of a financial instrument to account for
the instrument under the fair value option under ASC 825. The Company has made
such election for its Convertible Note. Using fair value option, the Convertible
Note is required to be recorded at its initial fair value on the date of
issuance, and each balance sheet date thereafter. Changes in the estimated fair
value of the note are recognized as
non-cash
change in the fair value of the Convertible Note in the condensed statements of
operations. The fair value of the option to convert into private warrants was
valued utilizing the closed-form model.

For issued or modified warrants that meet all of the criteria for equity
classification, the warrants are required to be recorded as a component of
additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not
meet all the criteria for equity classification, the warrants are required to be
recorded at their initial fair value on the date of issuance, and each balance
sheet date thereafter. Changes in the estimated fair value of the warrants are
recognized as a
non-cash
gain or loss on the statements of operations.

Class A Common Stock Subject to Possible Redemption

We account for our shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders' equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, all of the Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders' deficit section of our condensed balance sheets.


                                       21

--------------------------------------------------------------------------------

Table of Contents

Net Income (Loss) per Common Share



The Company complies with accounting and disclosure requirements of FASB ASC
Topic 260, "Earnings Per Share". Net income per common share is computed by
dividing net income by the weighted average number of common shares outstanding
for the period. The Company applies the
two-class
method in calculating income per common share.
Re-measurement
associated with the redeemable shares of Class A common stock is excluded from
income per common share as the redemption value approximates fair value.

The calculation of diluted income per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events, and (iii) any warrants that could be acquired through conversion of convertible debt. As of March 31, 2022 and December 31, 2021, there are currently 34,500,000 shares of Class A common stock in the aggregate which does not include the warrants that could be issued as a result of the conversion option in the Convertible Note. As of March 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income per common share is the same as basic net income per common share for the periods presented.

Recent Accounting Standards



In August 2020, the FASB issued Accounting Standards Update ("ASU")
2020-06-
"Contracts in Entity's Own Equity (Subtopic
815-40)
("ASU2020-06")",
to simplify accounting for certain financial instruments
ASU2020-06
eliminates the current models that require separation of beneficial conversion
and cash conversion features from convertible instruments and simplifies the
derivative scope exception guidance pertaining to equity classification of
contracts in an entity's own equity. The new standard also introduces additional
disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity's own equity.
ASU2020-06
amends the diluted earnings per share guidance, including the requirement to use
the
if-converted
method for all convertible instruments.
ASU2020-06
is effective for fiscal years beginning after December 15, 2023, including
interim periods within those fiscal years with early adoption permitted. We are
currently assessing the impact, if any, that
ASU2020-06
would have on its financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

© Edgar Online, source Glimpses